✦ LIBER ✦

Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting

✍ Scribed by Evgeny Klyuchnikov; Ernst Holler; Martin Bornhäuser; Guido Kobbe; Arnon Nagler; Avichai Shimoni; Christian Könecke; Christine Wolschke; Ulrike Bacher; Axel R. Zander; Nicolaus Kröger

Book ID: 117940113
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 167 KB
Volume: 159
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Azacitidine and donor lymphocyte infusio

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

✍ Schroeder, T; Czibere, A; Platzbecker, U; Bug, G; Uharek, L; Luft, T; Giagounidi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

Granulocyte Colony-Stimulating Factor-Pr

Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation

✍ Takeshi Kobayashi; Kazuteru Ohashi; Miwa Sakai; Takuya Yamashita; Yoshiki Okuyam 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 75 KB

Efficacy and toxicity of low-dose escala

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma

✍ Ayuk, F; Shimoni, A; Nagler, A; Schwerdtfeger, R; Kiehl, M; Sayer, H G; Zabelina 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 79 KB

Successful treatment with gemtuzumab ozo

Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation

✍ Takayoshi Tachibana; Masatsugu Tanaka; Hirotaka Takasaki; Ayumi Numata; Shin Fuj 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 240 KB

Reduced-intensity conditioning for allog

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes

✍ Karl S. Peggs; Anna Sureda; Wendi Qian; Dolores Caballero; Ann Hunter; Alvaro Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Donor Lymphocyte Infusions Modulate Rela

Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma

✍ Peggs, K. S.; Kayani, I.; Edwards, N.; Kottaridis, P.; Goldstone, A. H.; Linch, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 827 KB